Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04006899 · ClinicalTrials.gov registry record
Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement
A clinical trial of Medical Device, sponsored by Jun Choi.
- Completed
- Registry status
- 5
- Enrollment target
- 1
- Study location
NCT04006899: Completed study of Medical Device, sponsored by Jun Choi.
NCT04006899 is a study of Medical Device that has completed, run by Jun Choi. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04006899, a study of Medical Device, has completed, sponsored by Jun Choi.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric current.
Primary Outcome
Bioelectrical impedance values from three devices were measured and recorded.
Conditions Studied
Interventions
- DEVICE Bioelectrical Impedance Monitor
Study Locations (1)
Georgia
- Georgia Southern University - Statesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2019-05-30 |
What the finished NCT04006899 record still lists
NCT04006899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 1 condition, with Medical Device appearing as the primary indexed condition, and to 1 intervention - of which Bioelectrical Impedance Monitor is the first listed.
NCT04006899 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04006899 about?
NCT04006899 is a clinical study titled "Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement". A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric curre...
What is the current status of trial NCT04006899?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2018-06-20. Estimated completion is 2019-05-30.
What conditions does trial NCT04006899 study?
This clinical trial studies the following conditions: Medical Device.
What interventions are being tested in trial NCT04006899?
The interventions under investigation include: Bioelectrical Impedance Monitor (DEVICE).
Who is sponsoring clinical trial NCT04006899?
This trial is sponsored by Jun Choi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04006899 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medical Device
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI